Drug intelligence / Profile preview

feline GM-CSF

Development stage
Unknown
Lead developer
Bio-Techne
Modality
Recombinant Proteins and Enzymes
Administration
Intramuscular, Intravenous, Subcutaneous
01

Overview

Feline granulocyte-macrophage colony-stimulating factor (feline GM-CSF) is a hematopoietic cytokine that regulates the survival, proliferation, differentiation, and activation of feline myeloid cells, including granulocytes, macrophages, and dendritic cells. It exerts its biological effects by binding to the heterodimeric GM-CSF receptor complex, which consists of a ligand-binding alpha subunit (GM-CSF R alpha / CD116) and a signal-transducing common beta subunit (CD131). This binding triggers downstream signaling cascades, including the JAK/STAT, MAPK/ERK, and PI3K-AKT pathways. Feline GM-CSF is primarily utilized as a research-use-only recombinant protein to study feline immunology, hematopoiesis, and dendritic cell differentiation. It has also been investigated in experimental veterinary settings, such as an adjuvant in DNA vaccines or in gene therapy protocols for feline cancers and viral infections.

Other names
feline colony-stimulating factor 2feline CSF2feline granulocyte-macrophage colony-stimulating factorrecombinant feline GM-CSFrecombinant feline granulocyte-macrophage colony-stimulating factor
02

Targets

CSF2RB (Cytokine receptor common subunit beta)CSF2RA (Granulocyte-macrophage colony-stimulating factor receptor subunit alpha)

Beyond the preview

Go deeper on feline GM-CSF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on feline GM-CSF.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call